Walleye Capital LLC Verastem, Inc. Transaction History

Walleye Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$1.02 - $1.83 $186,038 - $333,775	182,391 New	182,391 $212,000
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $302,260 - $484,330	-119,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $305,830 - $577,150	119,000 New	119,000 $484,000
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.68 $22,200 - $33,600	-20,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.69 - $4.2 $13,520 - $33,600	-8,000 Reduced 28.57%	20,000 $34,000
Q1 2020 May 15, 2020	BUY	$1.26 - $3.38 $35,280 - $94,640	28,000 New	28,000 $74,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.17B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.